Mechanisms and Interventions Addressing Accelerated Cardiovascular Disease Risk in Women With Endometriosis
Latest Information Update: 20 Nov 2023
Price :
$35 *
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary) ; Simvastatin (Primary)
- Indications Cardiovascular disorders; Endometriosis; Vasomotor symptoms
- Focus Therapeutic Use
- Acronyms Endo2/SA3
- 25 Aug 2023 Planned primary completion date changed from 1 Jun 2025 to 31 Dec 2025.
- 15 Aug 2023 Planned End Date changed from 1 Dec 2026 to 31 Dec 2026.
- 15 Aug 2023 Planned primary completion date changed from 1 Dec 2025 to 1 Jun 2025.